Leukemia & Lymphoma, Volume 50, Issue 7 (2009)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 50, Issue 7 (2009)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Volume 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs Download issue

Commentary

Article Commentary
t(14;18) cells are getting hard to find
Peter McLaughlin
Pages: 1063-1064
Published online: 21 Jul 2009
Citationfort(14;18) cells are getting hard to find | Full Text | References | PDF (132.1 KB)
  • 20 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
‘Rapping’ on the door of drug resistance
Deborah Rund
Pages: 1065-1066
Published online: 21 Jul 2009
Citationfor‘Rapping’ on the door of drug resistance | Full Text | References | PDF (126.9 KB)
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
The stromal derived factor-1\CXCR4 axis – a legitimate therapeutic target in multiple myeloma?
Ben-Zion Katz & Sigal Tavor
Pages: 1067-1068
Published online: 21 Jul 2009
CitationforThe stromal derived factor-1\CXCR4 axis – a legitimate therapeutic target in multiple myeloma? | Full Text | References | PDF (130.3 KB)
  • 111 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
BH3-mimetics – the solution to chemoresistance?
Seong L. Khaw, David C. S. Huang & Andrew W. Roberts
Pages: 1069-1072
Published online: 21 Jul 2009
First Page PreviewforBH3-mimetics – the solution to chemoresistance? | Full Text | References | PDF (146.8 KB)
  • 81 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapy
Farhad Ravandi
Pages: 1073-1074
Published online: 21 Jul 2009
CitationforTherapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapy | Full Text | References | PDF (130.4 KB)
  • 38 Views
  • 4 CrossRef citations
  • 0Altmetric

Reviews

Review Article
B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity
Gerardo Ferrer, Kate Hodgson, Emili Montserrat & Carol Moreno
Pages: 1075-1082
Published online: 21 Jul 2009
AbstractforB cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity | Full Text | References | PDF (305.3 KB)
  • 182 Views
  • 18 CrossRef citations
  • 0Altmetric
Review Article
The late adverse events of rituximab therapy – rare but there!
Ron Ram, Isaac Ben-Bassat, Ofer Shpilberg, Aaron Polliack & Pia Raanani
Pages: 1083-1095
Published online: 21 Jul 2009
AbstractforThe late adverse events of rituximab therapy – rare but there! | Full Text | References | PDF (414.4 KB)
  • 1708 Views
  • 97 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial
Asher Chanan-Khan, Kena C. Miller, Laurie Musial, Swaminathan Padmanabhan, Jihnhee Yu, Sikander Ailawadhi, Taimur Sher, Alice Mohr, Zale P. Bernstein, Maurice Barcos, Mehul Patel, Dan Iancu, Kelvin Lee & Myron S. Czuczman
Pages: 1096-1101
Published online: 21 Jul 2009
AbstractforBortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial | Full Text | References | PDF (247.8 KB)
  • 234 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
The persistence of t(14;18)-bearing cells in lymph nodes of patients with follicular lymphoma in complete remission: the evidence for ‘a lymphoma stem cell’
Andrea Janikova, Jiri Mayer, Leos Kren, Jana Smardova, Dana Dvorakova, Jiri Neubauer & Ingrid Vasova
Pages: 1102-1109
Published online: 21 Jul 2009
AbstractforThe persistence of t(14;18)-bearing cells in lymph nodes of patients with follicular lymphoma in complete remission: the evidence for ‘a lymphoma stem cell’ | Full Text | References | PDF (453.7 KB)
  • 42 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma
Ji Eun Uhm, Kyoung Ha Kim, Seong Yoon Yi, Myung Hee Chang, Keon Woo Park, Doo-Sik Kong, Jung Il Lee, Do Hyun Nam, Won Park, Do Hoon Lim, Seok Jin Kim, Kihyun Kim, Young Hyeh Ko & Won Seog Kim
Pages: 1110-1118
Published online: 21 Jul 2009
AbstractforA retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma | Full Text | References | PDF (484.5 KB)
  • 124 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea
Myung Hee Chang, Seok Jin Kim, Kihyun Kim, Sung Yong Oh, Dae Ho Lee, Jooryung Huh, Young Hyeh Ko, Chul Won Choi, Deok-Hwan Yang, Jong Ho Won, Won Seog Kim & Cheolwon Suh
Pages: 1119-1125
Published online: 21 Jul 2009
AbstractforClinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea | Full Text | References | PDF (410.6 KB)
  • 243 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse
Anjali Advani, Tao Jin, Brian Bolwell, Edward Copelan, Mikkael Sekeres, Ronald Sobecks, Shawnda Sungren, Melissa Yurch & Matt Kalaycio
Pages: 1126-1131
Published online: 21 Jul 2009
AbstractforA prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse | Full Text | References | PDF (392.9 KB)
  • 68 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Improved treatment results in Mexican children with acute myeloid leukemia using a Medical Research Council (MRC)-acute myeloid leukemia 10 modified protocol
Sergio Gallegos-Castorena, Aurora Medina-Sanson, Oscar Gonzalez-Ramella, Fernando Sánchez-Zubieta & Armando Martínez-Avalos
Pages: 1132-1137
Published online: 21 Jul 2009
AbstractforImproved treatment results in Mexican children with acute myeloid leukemia using a Medical Research Council (MRC)-acute myeloid leukemia 10 modified protocol | Full Text | References | PDF (306.6 KB)
  • 86 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Acute leukemia among the adult population of United Arab Emirates: an epidemiological study
Inaam Bashir Hassan, Sherief I. A. M. Islam, Hussain Alizadeh, Jorgen Kristensen, Amr Kambal, Shanaaz Sonday & Roos M. D. Bernseen
Pages: 1138-1147
Published online: 21 Jul 2009
AbstractforAcute leukemia among the adult population of United Arab Emirates: an epidemiological study | Full Text | References | PDF (327.3 KB)
  • 189 Views
  • 5 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Cintia C. Mascarenhas, Anderson F. Cunha, Eliana C. Miranda, Roberto Zulli, Rosana A. Silveira, Fernando F. Costa, Kátia B. B. Pagnano & Cármino A. De Souza
Pages: 1148-1154
Published online: 21 Jul 2009
AbstractforNew mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors | Full Text | References | PDF (597.8 KB)
  • 192 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug-resistant B-cell lymphoma cell lines
Iliodora V. Pop, Laurentiu M. Pop, Maria-Ana Ghetie & Ellen S. Vitetta
Pages: 1155-1162
Published online: 21 Jul 2009
AbstractforTargeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug-resistant B-cell lymphoma cell lines | Full Text | References | PDF (821.2 KB)
  • 198 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells
Seong-Woo Kim, Ha-Yon Kim, Hyo-Jin Lee, Hwan-Jung Yun, Samyong Kim & Deog-Yeon Jo
Pages: 1163-1173
Published online: 21 Jul 2009
AbstractforDexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells | Full Text | References | PDF (1 MB)
  • 371 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737
Aarthi Jayanthan, Scott C. Howard, Tanya Trippett, Terzah Horton, James A. Whitlock, Lara Daisley, Victor Lewis & Aru Narendran
Pages: 1174-1182
Published online: 21 Jul 2009
AbstractforTargeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737 | Full Text | References | PDF (837.3 KB)
  • 218 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Function of retinoid acid receptor α and p21 in all-trans-retinoic acid-induced acute T-lymphoblastic leukemia apoptosis
Peihua Luo, Meili Lin, Meihua Lin, Yiyu Chen, Bo Yang & Qiaojun He
Pages: 1183-1189
Published online: 21 Jul 2009
AbstractforFunction of retinoid acid receptor α and p21 in all-trans-retinoic acid-induced acute T-lymphoblastic leukemia apoptosis | Full Text | References | PDF (474.4 KB)
  • 237 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Preferential expression of phosphatidylglucoside along neutrophil differentiation pathway
Satoko Oka, Yasuko Nagatsuka, Jiro Kikuchi, Taiji Yokote, Yoshio Hirabayashi, Toshiaki Hanafusa, Keiya Ozawa & Kazuo Muroi
Pages: 1190-1197
Published online: 21 Jul 2009
AbstractforPreferential expression of phosphatidylglucoside along neutrophil differentiation pathway | Full Text | References | PDF (768.1 KB)
  • 188 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide
Ann-Sofie Johansson, Sven-Christian Pawelzik, Åsa Larefalk, Per-Johan Jakobsson, Dan Holmberg & Magnus Lindskog
Pages: 1198-1203
Published online: 21 Jul 2009
AbstractforLymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide | Full Text | References | PDF (291 KB)
  • 83 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells
Azhar R. Hussain, Maqbool Ahmed, Saeeda O. Ahmed, Sara Al-Thari, Asma S. Khan, Shirin Razack, Leonidas C. Platanias, Khawla S. Al-Kuraya & Shahab Uddin
Pages: 1204-1213
Published online: 21 Jul 2009
AbstractforProteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells | Full Text | References | PDF (955.3 KB)
  • 190 Views
  • 25 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma
Savina Maria Luciana Aversa, Chiara Trentin, Mariella Sorarů, Eros Di Bona, Dario Marino, Fabio Canova, Luigi Salvagno & Fausto Adami
Pages: 1214-1216
Published online: 21 Jul 2009
First Page PreviewforAcute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma | Full Text | References | PDF (137.3 KB)
  • 42 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Use of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone
Emanuele Ammatuna, Enrico Montefusco, Matteo Pacilli, Mariadomenica Divona, Davide Ardiri, Diego Centonze & Francesco Lo-Coco
Pages: 1217-1218
Published online: 21 Jul 2009
CitationforUse of arsenic trioxide in secondary acute promyelocytic leukemia developing after treatment of multiple sclerosis with mitoxantrone | Full Text | References | PDF (131.8 KB)
  • 50 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Primary intestinal diffuse large B-cell lymphoma presenting as multiple lymphomatous polyposis
Sheau-Fang Yang, Yung-Liang Liao, Szu-Yin Kuo, Hongtao Ye, Sheng-Fung Lin, Fang-Ming Chen, Chiao-Yun Chen & Shih-Sung Chuang
Pages: 1219-1222
Published online: 21 Jul 2009
First Page PreviewforPrimary intestinal diffuse large B-cell lymphoma presenting as multiple lymphomatous polyposis | Full Text | References | PDF (698.3 KB)
  • 43 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
S-phase fraction as response marker in patients with chronic myeloid leukemia
Anil Kumar Tripathi, Payal Tripathi, Rizwan Ahmad, Parijat Deb Chaudhary & Shailendra Kumar Verma
Pages: 1223-1225
Published online: 21 Jul 2009
First Page PreviewforS-phase fraction as response marker in patients with chronic myeloid leukemia | Full Text | References | PDF (189 KB)
  • 35 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumor lysis in a patient with peripheral T-cell lymphoma unspecified
Yuji Hirata, Taiji Yokote, Kichinosuke Kobayashi, Shoko Nakayama, Takuji Miyoshi, Toshikazu Akioka, Motomu Tsuji, Takayuki Takubo & Toshiaki Hanafusa
Pages: 1226-1229
Published online: 21 Jul 2009
First Page PreviewforSyndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumor lysis in a patient with peripheral T-cell lymphoma unspecified | Full Text | References | PDF (786.3 KB)
  • 145 Views
  • 6 CrossRef citations
  • 0Altmetric

Correspondence

Article
Clofarabine in relapsed lymphoma: what is the optimal dose?
Chadi Nabhan
Pages: 1230-1231
Published online: 21 Jul 2009
CitationforClofarabine in relapsed lymphoma: what is the optimal dose? | Full Text | References | PDF (128.6 KB)
  • 52 Views
  • 1 CrossRef citations
  • 0Altmetric
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma
Kristie A. Blum, Mehdi Hamadani, Gary S. Phillips, Gerard Lozanski, Amy J. Johnson, David M. Lucas, Lisa L. Smith, Robert Baiocchi, Thomas S. Lin, Pierluigi Porcu, Steven M. Devine & John C. Byrd
Pages: 1232-1234
Published online: 21 Jul 2009
First Page PreviewforProlonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma | Full Text | References | PDF (134.7 KB)
  • 20 Views
  • 0 CrossRef citations
  • 0Altmetric

Corrigenda

Corrigendum 1
Page: 1235
Published online: 21 Jul 2009
CitationforCorrigendum 1 | Full Text | PDF (117.2 KB)
  • 253 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles